{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:49:13Z","timestamp":1793504953615,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05963-5","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:40:00Z","timestamp":1734698400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unraveling the interplay of CD8\u2009+\u2009T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches"],"prefix":"10.1186","volume":"22","author":[{"given":"Arefeh","family":"Zabeti Touchaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1794-0563","authenticated-orcid":false,"given":"Sogand","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"2","key":"5963_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3892\/mi.2023.80","volume":"3","author":"AA Elkhodiry","year":"2023","unstructured":"Elkhodiry AA, Zamzam DA, El Tayebi HM. MicroRNA-155 modulation of CD8(+) T-cell activity personalizes response to disease-modifying therapies of patients with relapsing-remitting multiple sclerosis. Med Int. 2023;3(2):20.","journal-title":"Med Int"},{"key":"5963_CR2","doi-asserted-by":"publisher","first-page":"107201","DOI":"10.1016\/j.intimp.2020.107201","volume":"90","author":"AA Samadani","year":"2021","unstructured":"Samadani AA, Keymoradzdeh A, Shams S, Soleymanpour A, Rashidy-Pour A, Hashemian H, et al. CAR T-cells profiling in carcinogenesis and tumorigenesis: an overview of CAR T-cells cancer therapy. Int Immunopharmacol. 2021;90:107201.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5963_CR3","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234(6):8509\u201321.","journal-title":"J Cell Physiol"},{"issue":"4","key":"5963_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8(+) T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"5963_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","volume":"18","author":"R Spolski","year":"2018","unstructured":"Spolski R, Li P, Leonard WJ. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat Rev Immunol. 2018;18(10):648\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5963_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-019-0734-5","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L, et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol. 2019;12(1):51.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"5963_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203\u201322.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"5963_CR8","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.5001\/omj.2020.93","volume":"36","author":"SE Norollahi","year":"2021","unstructured":"Norollahi SE, Foumani MG, Pishkhan MK, Shafaghi A, Alipour M, Jamkhaneh VB, et al. DNA methylation profiling of MYC, SMAD2\/3 and DNMT3A in colorectal cancer. Oman Med J. 2021;36(6):e315.","journal-title":"Oman Med J"},{"issue":"11","key":"5963_CR9","first-page":"6097","volume":"24","author":"DC Gao","year":"2020","unstructured":"Gao DC, Hou B, Zhou D, Liu QX, Zhang K, Lu X, et al. Tumor-derived exosomal miR-103a-2-5p facilitates esophageal squamous cell carcinoma cell proliferation and migration. Eur Rev Med Pharmacol Sci. 2020;24(11):6097\u2013110.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5963_CR10","doi-asserted-by":"publisher","first-page":"108958","DOI":"10.1016\/j.biopha.2019.108958","volume":"115","author":"SE Norollahi","year":"2019","unstructured":"Norollahi SE, Mansour-Ghanaei F, Joukar F, Ghadarjani S, Mojtahedi K, Gharaei Nejad K, et al. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomed Pharmacother. 2019;115:108958.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5963_CR11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1021\/acs.molpharmaceut.3c01040","volume":"21","author":"R Pandey","year":"2024","unstructured":"Pandey R, Chiu CC, Wang LF. Immunotherapy study on non-small-cell lung cancer (NSCLC) combined with cytotoxic T cells and miRNA34a. Mol Pharm. 2024;21(3):1364\u201381.","journal-title":"Mol Pharm"},{"issue":"17","key":"5963_CR12","doi-asserted-by":"publisher","first-page":"e2106083119","DOI":"10.1073\/pnas.2106083119","volume":"119","author":"E Stelekati","year":"2022","unstructured":"Stelekati E, Cai Z, Manne S, Chen Z, Beltra JC, Buchness LA, et al. MicroRNA-29a attenuates CD8 T cell exhaustion and induces memory-like CD8 T cells during chronic infection. Proc Natl Acad Sci U S A. 2022;119(17):e2106083119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"5963_CR13","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.celrep.2017.08.060","volume":"20","author":"Z Chen","year":"2017","unstructured":"Chen Z, Stelekati E, Kurachi M, Yu S, Cai Z, Manne S, et al. miR-150 regulates memory CD8 T cell differentiation via c-Myb. Cell Rep. 2017;20(11):2584\u201397.","journal-title":"Cell Rep"},{"issue":"1","key":"5963_CR14","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1038\/s41467-023-40959-7","volume":"14","author":"AC Wells","year":"2023","unstructured":"Wells AC, Hioki KA, Angelou CC, Lynch AC, Liang X, Ryan DJ, et al. Let-7 enhances murine anti-tumor CD8 T cell responses by promoting memory and antagonizing terminal differentiation. Nat Commun. 2023;14(1):5585.","journal-title":"Nat Commun"},{"key":"5963_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbrc.2021.03.090","volume":"554","author":"X Jia","year":"2021","unstructured":"Jia X, Wei Y, Miao X, Zhu T, Hu X, Lin Z, et al. Deficiency of miR-15a\/16 upregulates NKG2D in CD8(+) T cells to exacerbate dextran sulfate sodium-induced colitis. Biochem Biophys Res Commun. 2021;554:114\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5963_CR16","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1038\/s41467-019-09882-8","volume":"10","author":"Y Ji","year":"2019","unstructured":"Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, et al. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019;10(1):2157.","journal-title":"Nat Commun"},{"issue":"11","key":"5963_CR17","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1016\/j.celrep.2017.08.065","volume":"20","author":"YH Ban","year":"2017","unstructured":"Ban YH, Oh SC, Seo SH, Kim SM, Choi IP, Greenberg PD, et al. miR-150-mediated Foxo1 regulation programs CD8(+) T cell differentiation. Cell Rep. 2017;20(11):2598\u2013611.","journal-title":"Cell Rep"},{"issue":"29","key":"5963_CR18","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1038\/onc.2017.62","volume":"36","author":"W He","year":"2017","unstructured":"He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36(29):4212\u201323.","journal-title":"Oncogene"},{"key":"5963_CR19","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/ncomms6241","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA, et al. Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun. 2014;5:5241.","journal-title":"Nat Commun"},{"key":"5963_CR20","doi-asserted-by":"publisher","first-page":"116173","DOI":"10.1016\/j.biopha.2024.116173","volume":"171","author":"RQ Li","year":"2024","unstructured":"Li RQ, Yang Y, Qiao L, Yang L, Shen DD, Zhao XJ. KIF2C: an important factor involved in signaling pathways, immune infiltration, and DNA damage repair in tumorigenesis. Biomed Pharmacother. 2024;171:116173.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5963_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/21655979.2021.2017566","volume":"13","author":"W Fang","year":"2022","unstructured":"Fang W, Shi C, Wang Y, Song J, Zhang L. microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer. Bioengineered. 2022;13(1):1025\u201338.","journal-title":"Bioengineered"},{"issue":"3","key":"5963_CR22","first-page":"2484","volume":"20","author":"M Zhao","year":"2019","unstructured":"Zhao M, Liu Q, Liu W, Zhou H, Zang X, Lu J. MicroRNA-140 suppresses Helicobacter pylori-positive gastric cancer growth by enhancing the antitumor immune response. Mol Med Rep. 2019;20(3):2484\u201392.","journal-title":"Mol Med Rep"},{"key":"5963_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.05.037","volume":"518","author":"C Miliotis","year":"2021","unstructured":"Miliotis C, Slack FJ. miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer. Cancer Lett. 2021;518:115\u201326.","journal-title":"Cancer Lett"},{"issue":"10","key":"5963_CR24","doi-asserted-by":"publisher","first-page":"894","DOI":"10.18632\/oncotarget.27520","volume":"11","author":"C Prinz","year":"2020","unstructured":"Prinz C, Weber D. MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155. Oncotarget. 2020;11(10):894\u2013904.","journal-title":"Oncotarget"},{"issue":"4","key":"5963_CR25","first-page":"322","volume":"57","author":"A Shafaghi","year":"2019","unstructured":"Shafaghi A, Gharibpoor F, Mahdipour Z, Samadani AA. Comparison of three risk scores to predict outcomes in upper gastrointestinal bleeding; modifying Glasgow-Blatchford with albumin. Rom J Intern Med. 2019;57(4):322\u201333.","journal-title":"Rom J Intern Med"},{"issue":"13","key":"5963_CR26","doi-asserted-by":"publisher","first-page":"e2308688","DOI":"10.1002\/smll.202308688","volume":"20","author":"C Lu","year":"2024","unstructured":"Lu C, Xie L, Qiu S, Jiang T, Wang L, Chen Z, et al. Small Extracellular vesicles derived from helicobacter pylori-infected gastric cancer cells induce lymphangiogenesis and lymphatic remodeling via transfer of miR-1246. Small. 2024;20(13):e2308688.","journal-title":"Small"},{"issue":"2","key":"5963_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3831\/KPI.2022.25.2.88","volume":"25","author":"S Vahidi","year":"2022","unstructured":"Vahidi S, Mirzajani E, Norollahi SE, Aziminezhad M, Samadani AA. Performance of DNA methylation on the molecular pathogenesis of helicobacter pylori in gastric cancer; targeted therapy approach. J Pharmacopuncture. 2022;25(2):88\u2013100.","journal-title":"J Pharmacopuncture"},{"issue":"1","key":"5963_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40425-019-0691-0","volume":"7","author":"Q Lou","year":"2019","unstructured":"Lou Q, Liu R, Yang X, Li W, Huang L, Wei L, et al. miR-448 targets IDO1 and regulates CD8(+) T cell response in human colon cancer. J Immunother Cancer. 2019;7(1):210.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"5963_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12079-022-00697-9","volume":"17","author":"P Morovat","year":"2023","unstructured":"Morovat P, Morovat S, Hosseinpour M, Moslabeh FGZ, Kamali MJ, Samadani AA. Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis\/prognosis of thyroid cancer. J Cell Commun Signal. 2023;17(3):639\u201355.","journal-title":"J Cell Commun Signal"},{"issue":"11","key":"5963_CR30","doi-asserted-by":"publisher","first-page":"e005241","DOI":"10.1136\/jitc-2022-005241","volume":"10","author":"M Jiang","year":"2022","unstructured":"Jiang M, Yang Y, Niu L, Li P, Chen Y, Liao P, Wang Y, Zheng J, Chen F, He H, Li H, Chen X. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2. J Immunother Cancer. 2022;10(11):e005241.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"5963_CR31","doi-asserted-by":"publisher","first-page":"e21776","DOI":"10.1096\/fj.202100235R","volume":"35","author":"J Zheng","year":"2021","unstructured":"Zheng J, Yang T, Gao S, Cheng M, Shao Y, Xi Y, et al. miR-148a-3p silences the CANX\/MHC-I pathway and impairs CD8(+) T cell-mediated immune attack in colorectal cancer. Faseb j. 2021;35(8):e21776.","journal-title":"Faseb j"},{"issue":"1","key":"5963_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s11658-024-00539-z","volume":"29","author":"W Du","year":"2024","unstructured":"Du W, Quan X, Wang C, Song Q, Mou J, Pei D. Regulation of tumor metastasis and CD8(+) T cells infiltration by circRNF216\/miR-576-5p\/ZC3H12C axis in colorectal cancer. Cell Mol Biol Lett. 2024;29(1):19.","journal-title":"Cell Mol Biol Lett"},{"issue":"16","key":"5963_CR33","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2217\/epi-2021-0130","volume":"13","author":"YJ Xu","year":"2021","unstructured":"Xu YJ, Zhao JM, Ni XF, Wang W, Hu WW, Wu CP. LncRNA HCG18 suppresses CD8(+) T cells to confer resistance to cetuximab in colorectal cancer via miR-20b-5p\/PD-L1 axis. Epigenomics. 2021;13(16):1281\u201397.","journal-title":"Epigenomics"},{"issue":"15","key":"5963_CR34","doi-asserted-by":"publisher","first-page":"e2304222","DOI":"10.1002\/advs.202304222","volume":"11","author":"Y Feng","year":"2024","unstructured":"Feng Y, Jin C, Wang T, Chen Z, Ji D, Zhang Y, et al. The uridylyl transferase TUT7-mediated accumulation of exosomal miR-1246 reprograms TAMs to support CRC progression. Adv Sci (Weinh). 2024;11(15):e2304222.","journal-title":"Adv Sci (Weinh)"},{"key":"5963_CR35","doi-asserted-by":"publisher","first-page":"30923","DOI":"10.1038\/srep30923","volume":"6","author":"T Yu","year":"2016","unstructured":"Yu T, Zuo QF, Gong L, Wang LN, Zou QM, Xiao B. MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells. Sci Rep. 2016;6:30923.","journal-title":"Sci Rep"},{"key":"5963_CR36","doi-asserted-by":"publisher","first-page":"653808","DOI":"10.3389\/fcell.2021.653808","volume":"9","author":"D Xian","year":"2021","unstructured":"Xian D, Niu L, Zeng J, Wang L. LncRNA KCNQ1OT1 secreted by tumor cell-derived exosomes mediates immune escape in colorectal cancer by regulating PD-L1 ubiquitination via MiR-30a-5p\/USP22. Front Cell Dev Biol. 2021;9:653808.","journal-title":"Front Cell Dev Biol"},{"key":"5963_CR37","doi-asserted-by":"publisher","first-page":"107822","DOI":"10.1016\/j.intimp.2021.107822","volume":"97","author":"C Wang","year":"2021","unstructured":"Wang C, Li X, Zhang L, Chen Y, Dong R, Zhang J, et al. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. Int Immunopharmacol. 2021;97:107822.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5963_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12957-021-02461-6","volume":"20","author":"Z Yan","year":"2022","unstructured":"Yan Z, Lijuan Y, Yinhang W, Yin J, Jiamin X, Wei W, et al. Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer. World J Surg Oncol. 2022;20(1):2.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"5963_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10142-024-01302-5","volume":"24","author":"X Li","year":"2024","unstructured":"Li X, Wu A, Wang Y, Li D, Wu M. Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8(+) T cells to alleviate hepatocellular carcinoma. Funct Integr Genomics. 2024;24(1):27.","journal-title":"Funct Integr Genomics"},{"key":"5963_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2019.01.019","volume":"110","author":"K Yan","year":"2019","unstructured":"Yan K, Fu Y, Zhu N, Wang Z, Hong JL, Li Y, et al. Repression of lncRNA NEAT1 enhances the antitumor activity of CD8(+)T cells against hepatocellular carcinoma via regulating miR-155\/Tim-3. Int J Biochem Cell Biol. 2019;110:1\u20138.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"5963_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, et al. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023;22(1):55.","journal-title":"Mol Cancer"},{"issue":"4","key":"5963_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10142-023-01231-9","volume":"23","author":"X Yu","year":"2023","unstructured":"Yu X, Fan X, Zhang X, Wei P, Zhou H, Liu D, et al. miR-429 inhibits the formation of an immunosuppressive microenvironment to counteract hepatocellular carcinoma immune escape by targeting PD-L1. Funct Integr Genomics. 2023;23(4):312.","journal-title":"Funct Integr Genomics"},{"issue":"8","key":"5963_CR43","first-page":"1642","volume":"71","author":"N Liu","year":"2022","unstructured":"Liu N, Wang X, Steer CJ, Song G. MicroRNA-206 promotes the recruitment of CD8(+) T cells by driving M1 polarisation of Kupffer cells. Gut. 2022;71(8):1642\u201355.","journal-title":"Gut"},{"issue":"1","key":"5963_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1158\/0008-5472.CAN-21-2269","volume":"82","author":"H Sendi","year":"2022","unstructured":"Sendi H, Yazdimamaghani M, Hu M, Sultanpuram N, Wang J, Moody AS, et al. Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis. Cancer Res. 2022;82(1):105\u201313.","journal-title":"Cancer Res"},{"issue":"12","key":"5963_CR45","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2174\/1386207326666221226155948","volume":"26","author":"H Deng","year":"2023","unstructured":"Deng H, Shi H, Yuan X, Zhang J. Mir-21-5p and Mir-455-5p as markers for diagnosis and prognosis of rectal adenocarcinoma may reduce local CD4(+) and CD8(+) lymphocyte infiltration. Comb Chem High Throughput Screen. 2023;26(12):2149\u201360.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"1","key":"5963_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y, et al. circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32.","journal-title":"Cell Death Dis"},{"issue":"5","key":"5963_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/10799893.2021.2019274","volume":"42","author":"J Li","year":"2022","unstructured":"Li J, Che L, Xu C, Lu D, Xu Y, Liu M, et al. XIST\/miR-34a-5p\/PDL1 axis regulated the development of lung cancer cells and the immune function of CD8(+) T cells. J Recept Signal Transduct Res. 2022;42(5):469\u201378.","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"5963_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12964-024-01570-5","volume":"22","author":"JY Choi","year":"2024","unstructured":"Choi JY, Seok HJ, Lee DH, Lee E, Kim TJ, Bae S, et al. Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization. Cell Commun Signal. 2024;22(1):190.","journal-title":"Cell Commun Signal"},{"key":"5963_CR49","doi-asserted-by":"publisher","first-page":"2960773","DOI":"10.1155\/2022\/2960773","volume":"2022","author":"H Ge","year":"2022","unstructured":"Ge H, Wang L, Chen W, Wang L. Mechanism of miR-760 reversing lung cancer immune escape by downregulating IDO1 and eliminating regulatory T cells based on mathematical biology. Comput Math Methods Med. 2022;2022:2960773.","journal-title":"Comput Math Methods Med"},{"key":"5963_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1479-5876-11-71","volume":"11","author":"G Zhong","year":"2013","unstructured":"Zhong G, Cheng X, Long H, He L, Qi W, Xiang T, et al. Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma. J Transl Med. 2013;11:71.","journal-title":"J Transl Med"},{"issue":"1","key":"5963_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-019-1024-0","volume":"18","author":"X Li","year":"2019","unstructured":"Li X, Zhong M, Wang J, Wang L, Lin Z, Cao Z, et al. miR-301a promotes lung tumorigenesis by suppressing Runx3. Mol Cancer. 2019;18(1):99.","journal-title":"Mol Cancer"},{"issue":"17","key":"5963_CR52","doi-asserted-by":"publisher","first-page":"e2100629","DOI":"10.1002\/advs.202100629","volume":"8","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Pan J, Xiong D, Wang Y, Miller MS, Sei S, et al. Pulmonary aerosol delivery of Let-7b microRNA confers a striking inhibitory effect on lung carcinogenesis through targeting the tumor immune microenvironment. Adv Sci (Weinh). 2021;8(17):e2100629.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"5963_CR53","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s43018-022-00444-4","volume":"3","author":"F Shao","year":"2022","unstructured":"Shao F, Gao Y, Wang W, He H, Xiao L, Geng X, et al. Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade. Nat Cancer. 2022;3(10):1192\u2013210.","journal-title":"Nat Cancer"},{"issue":"1","key":"5963_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-021-01448-x","volume":"20","author":"SW Chen","year":"2021","unstructured":"Chen SW, Zhu SQ, Pei X, Qiu BQ, Xiong D, Long X, et al. Cancer cell-derived exosomal circUSP7 induces CD8(+) T cell dysfunction and anti-PD1 resistance by regulating the miR-934\/SHP2 axis in NSCLC. Mol Cancer. 2021;20(1):144.","journal-title":"Mol Cancer"},{"issue":"2","key":"5963_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41419-022-04542-0","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Yang Z, Yang X, Zhang F, Wang J, Wu Z, et al. LINC01123 promotes immune escape by sponging miR-214-3p to regulate B7\u2013H3 in head and neck squamous-cell carcinoma. Cell Death Dis. 2022;13(2):109.","journal-title":"Cell Death Dis"},{"issue":"6","key":"5963_CR56","first-page":"2486","volume":"23","author":"C Qiu","year":"2019","unstructured":"Qiu C, Ma J, Wang ML, Zhang Q, Li YB. MicroRNA-155 deficiency in CD8+ T cells inhibits its anti-glioma immunity by regulating FoxO3a. Eur Rev Med Pharmacol Sci. 2019;23(6):2486\u201396.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"5963_CR57","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/ijc.30912","volume":"141","author":"J Yang","year":"2017","unstructured":"Yang J, Liu R, Deng Y, Qian J, Lu Z, Wang Y, et al. MiR-15a\/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR. Int J Cancer. 2017;141(10):2082\u201392.","journal-title":"Int J Cancer"},{"issue":"23","key":"5963_CR58","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1111\/jcmm.16909","volume":"25","author":"Y Ai","year":"2021","unstructured":"Ai Y, Wu S, Gao H, Wei H, Tang Z, Li X, et al. Repression of CRNDE enhances the anti-tumour activity of CD8 + T cells against oral squamous cell carcinoma through regulating miR-545-5p and TIM-3. J Cell Mol Med. 2021;25(23):10857\u201368.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"5963_CR59","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/cbin.11581","volume":"45","author":"Z Yang","year":"2021","unstructured":"Yang Z, Chen W, Wang Y, Qin M, Ji Y. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression. Cell Biol Int. 2021;45(7):1423\u201335.","journal-title":"Cell Biol Int"},{"issue":"8","key":"5963_CR60","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00262-020-02753-y","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang Y, Zheng J, Yao C, Lu X. LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a\/PD-L1 pathway. Cancer Immunol Immunother. 2021;70(8):2235\u201345.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"5963_CR61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13046-020-01752-2","volume":"39","author":"Y Xu","year":"2020","unstructured":"Xu Y, Liu Z, Lv L, Li P, Xiu B, Qian W, et al. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8(+) T lymphocytes in human diffuse large B cell lymphoma. J Exp Clin Cancer Res. 2020;39(1):238.","journal-title":"J Exp Clin Cancer Res"},{"key":"5963_CR62","doi-asserted-by":"publisher","first-page":"116335","DOI":"10.1016\/j.lfs.2019.03.040","volume":"231","author":"QM Wang","year":"2019","unstructured":"Wang QM, Lian GY, Song Y, Huang YF, Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335.","journal-title":"Life Sci"},{"issue":"1","key":"5963_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","volume":"18","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, et al. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Mol Cancer. 2019;18(1):54.","journal-title":"Mol Cancer"},{"issue":"6","key":"5963_CR64","doi-asserted-by":"publisher","first-page":"e004381","DOI":"10.1136\/jitc-2021-004381","volume":"10","author":"W Guo","year":"2022","unstructured":"Guo W, Wu Z, Chen J, Guo S, You W, Wang S, et al. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. J Immunother Cancer. 2022;10(6):e004381.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"5963_CR65","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-18-0504","volume":"7","author":"A Martinez-Usatorre","year":"2019","unstructured":"Martinez-Usatorre A, Sempere LF, Carmona SJ, Carretero-Iglesia L, Monnot G, Speiser DE, et al. MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma. Cancer Immunol Res. 2019;7(6):1013\u201324.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"5963_CR66","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/tox.23687","volume":"38","author":"X Wang","year":"2023","unstructured":"Wang X, Ren Z, Xu Y, Gao X, Huang H, Zhu F. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3\/PD-L1 axis. Environ Toxicol. 2023;38(2):368\u201380.","journal-title":"Environ Toxicol"},{"issue":"10","key":"5963_CR67","doi-asserted-by":"publisher","first-page":"190061","DOI":"10.1098\/rsob.190061","volume":"9","author":"M Zhang","year":"2019","unstructured":"Zhang M, Gao D, Shi Y, Wang Y, Joshi R, Yu Q, et al. miR-149-3p reverses CD8(+) T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells. Open Biol. 2019;9(10):190061.","journal-title":"Open Biol"},{"key":"5963_CR68","doi-asserted-by":"publisher","first-page":"5938688","DOI":"10.1155\/2022\/5938688","volume":"2022","author":"LM Guo","year":"2022","unstructured":"Guo LM, Ding GF, Xu WC, Ge H, Jiang Y, Lu YF. Anti-PD-L1 antibody enhances T cell immune responses and reduces resistance of breast cancer cells to radiotherapy. Oxid Med Cell Longev. 2022;2022:5938688.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"5963_CR69","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/cas.16036","volume":"115","author":"W Li","year":"2024","unstructured":"Li W, Han G, Li F, Bu P, Hao Y, Huang L, et al. Cancer cell-derived exosomal miR-20a-5p inhibits CD8(+) T-cell function and confers anti-programmed cell death 1 therapy resistance in triple-negative breast cancer. Cancer Sci. 2024;115(2):347\u201356.","journal-title":"Cancer Sci"},{"issue":"6","key":"5963_CR70","doi-asserted-by":"publisher","first-page":"e005461","DOI":"10.1136\/jitc-2022-005461","volume":"11","author":"LF Dong","year":"2023","unstructured":"Dong LF, Chen FF, Fan YF, Zhang K, Chen HH. circ-0000512 inhibits PD-L1 ubiquitination through sponging miR-622\/CMTM6 axis to promote triple-negative breast cancer and immune escape. J Immunother Cancer. 2023;11(6):e005461.","journal-title":"J Immunother Cancer"},{"key":"5963_CR71","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12967-016-0841-9","volume":"14","author":"M Gigante","year":"2016","unstructured":"Gigante M, Pontrelli P, Herr W, Gigante M, D\u2019Avenia M, Zaza G, et al. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. J Transl Med. 2016;14:84.","journal-title":"J Transl Med"},{"issue":"3","key":"5963_CR72","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00262-022-03305-2","volume":"72","author":"L Yin","year":"2023","unstructured":"Yin L, Wang Y. Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1\/miR-101-3p\/ZEB1\/PD-L1 axis. Cancer Immunol Immunother. 2023;72(3):743\u201358.","journal-title":"Cancer Immunol Immunother"},{"key":"5963_CR73","doi-asserted-by":"publisher","first-page":"100725","DOI":"10.1016\/j.omto.2023.09.001","volume":"31","author":"R Chen","year":"2023","unstructured":"Chen R, Coleborn E, Bhavsar C, Wang Y, Alim L, Wilkinson AN, et al. miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8(+) T cell infiltration. Mol Ther Oncolytics. 2023;31:100725.","journal-title":"Mol Ther Oncolytics"},{"issue":"11","key":"5963_CR74","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.7150\/thno.58337","volume":"11","author":"WJ Zhou","year":"2021","unstructured":"Zhou WJ, Zhang J, Xie F, Wu JN, Ye JF, Wang J, et al. CD45RO(-)CD8(+) T cell-derived exosomes restrict estrogen-driven endometrial cancer development via the ER\u03b2\/miR-765\/PLP2\/Notch axis. Theranostics. 2021;11(11):5330\u201345.","journal-title":"Theranostics"},{"issue":"3","key":"5963_CR75","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ymthe.2022.01.022","volume":"30","author":"C Yang","year":"2022","unstructured":"Yang C, Wu S, Mou Z, Zhou Q, Dai X, Ou Y, et al. Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Mol Ther. 2022;30(3):1054\u201370.","journal-title":"Mol Ther"},{"issue":"1","key":"5963_CR76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-024-01968-2","volume":"23","author":"X Shi","year":"2024","unstructured":"Shi X, Pang S, Zhou J, Yan G, Gao R, Wu H, et al. Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs. Mol Cancer. 2024;23(1):52.","journal-title":"Mol Cancer"},{"issue":"1","key":"5963_CR77","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-024-05070-5","volume":"22","author":"Q Cen","year":"2024","unstructured":"Cen Q, Chen J, Guo J, Chen M, Wang H, Wu S, et al. CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2\/HO-1 axis, regulating CD8 + T cell response. J Transl Med. 2024;22(1):278.","journal-title":"J Transl Med"},{"issue":"13","key":"5963_CR78","doi-asserted-by":"publisher","first-page":"e12168","DOI":"10.1002\/jev2.12168","volume":"10","author":"M Peng","year":"2021","unstructured":"Peng M, Ren J, Jing Y, Jiang X, Xiao Q, Huang J, et al. Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia. J Extracell Vesicles. 2021;10(13):e12168.","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"5963_CR79","doi-asserted-by":"publisher","first-page":"152111","DOI":"10.1016\/j.imbio.2021.152111","volume":"226","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wu J, Zeng C, Xu L, Wei W, Li Y. The role of NFAT2\/miR-20a-5p signaling pathway in the regulation of CD8(+) na\u00efve T cells activation and differentiation. Immunobiology. 2021;226(4):152111.","journal-title":"Immunobiology"},{"issue":"2","key":"5963_CR80","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.18632\/aging.102679","volume":"12","author":"Z Liu","year":"2020","unstructured":"Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12(2):1213\u201336.","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"5963_CR81","doi-asserted-by":"publisher","first-page":"2102620","DOI":"10.1002\/advs.202102620","volume":"9","author":"Y Yin","year":"2022","unstructured":"Yin Y, Liu B, Cao Y, Yao S, Liu Y, Jin G, et al. Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages. Adv Sci (Weinh). 2022;9(9):2102620.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"5963_CR82","doi-asserted-by":"publisher","first-page":"e12287","DOI":"10.1002\/jev2.12287","volume":"11","author":"D Jung","year":"2022","unstructured":"Jung D, Shin S, Kang SM, Jung I, Ryu S, Noh S, et al. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery. J Extracell Vesicles. 2022;11(12):e12287.","journal-title":"J Extracell Vesicles"},{"key":"5963_CR83","doi-asserted-by":"publisher","first-page":"121765","DOI":"10.1016\/j.biomaterials.2022.121765","volume":"289","author":"S Shin","year":"2022","unstructured":"Shin S, Jung I, Jung D, Kim CS, Kang SM, Ryu S, et al. Novel antitumor therapeutic strategy using CD4(+) T cell-derived extracellular vesicles. Biomaterials. 2022;289:121765.","journal-title":"Biomaterials"},{"key":"5963_CR84","doi-asserted-by":"publisher","first-page":"110121","DOI":"10.1016\/j.intimp.2023.110121","volume":"119","author":"C Wu","year":"2023","unstructured":"Wu C, Cao X, Xu J, Wang L, Huang J, Wen J, et al. Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p. Int Immunopharmacol. 2023;119:110121.","journal-title":"Int Immunopharmacol"},{"issue":"50","key":"5963_CR85","doi-asserted-by":"publisher","first-page":"34595","DOI":"10.1074\/jbc.M114.614503","volume":"289","author":"B Tang","year":"2014","unstructured":"Tang B, Wu W, Wei X, Li Y, Ren G, Fan W. Activation of glioma cells generates immune tolerant NKT cells. J Biol Chem. 2014;289(50):34595\u2013600.","journal-title":"J Biol Chem"},{"issue":"2","key":"5963_CR86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/07357907.2014.988344","volume":"33","author":"S Zhang","year":"2015","unstructured":"Zhang S, Guo Y, Zhang C, Gao W, Wen S, Huangfu H, et al. Primary laryngeal cancer-derived miR-193b induces interleukin-10-expression monocytes. Cancer Invest. 2015;33(2):29\u201333.","journal-title":"Cancer Invest"},{"key":"5963_CR87","doi-asserted-by":"publisher","first-page":"112156","DOI":"10.1016\/j.intimp.2024.112156","volume":"133","author":"S Vahidi","year":"2024","unstructured":"Vahidi S, Zabeti Touchaei A, Samadani AA. IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: from bench to bedside. Int Immunopharmacol. 2024;133:112156.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5963_CR88","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/cmi.2014.129","volume":"12","author":"BP Miao","year":"2015","unstructured":"Miao BP, Zhang RS, Li M, Fu YT, Zhao M, Liu ZG, et al. Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells. Cell Mol Immunol. 2015;12(6):750\u20136.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"5963_CR89","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2012.12.006","volume":"38","author":"JC Dudda","year":"2013","unstructured":"Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, et al. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity. 2013;38(4):742\u201353.","journal-title":"Immunity"},{"issue":"13","key":"5963_CR90","doi-asserted-by":"publisher","first-page":"e2304991","DOI":"10.1002\/advs.202304991","volume":"11","author":"L Wang","year":"2024","unstructured":"Wang L, Shen K, Gao Z, Ren M, Wei C, Yang Y, et al. Melanoma derived exosomes amplify radiotherapy induced abscopal effect via IRF7\/I-IFN axis in macrophages. Adv Sci (Weinh). 2024;11(13):e2304991.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"5963_CR91","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1159\/000491909","volume":"48","author":"Z Tao","year":"2018","unstructured":"Tao Z, Xu S, Ruan H, Wang T, Song W, Qian L, et al. MiR-195\/-16 family enhances radiotherapy via T cell activation in the tumor microenvironment by blocking the PD-L1 immune checkpoint. Cell Physiol Biochem. 2018;48(2):801\u201314.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"5963_CR92","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1158\/2326-6066.CIR-22-0318","volume":"11","author":"KC Huang","year":"2023","unstructured":"Huang KC, Lai CY, Hung WZ, Chang HY, Lin PC, Chiang SF, et al. A novel engineered AAV-based neoantigen vaccine in combination with radiotherapy eradicates tumors. Cancer Immunol Res. 2023;11(1):123\u201336.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"5963_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-024-03293-6","volume":"24","author":"A Zabeti Touchaei","year":"2024","unstructured":"Zabeti Touchaei A, Vahidi S. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1\/PD-L1 and CTLA-4 pathways. Cancer Cell Int. 2024;24(1):102.","journal-title":"Cancer Cell Int"},{"key":"5963_CR94","doi-asserted-by":"publisher","first-page":"925241","DOI":"10.3389\/fimmu.2022.925241","volume":"13","author":"P Autin","year":"2022","unstructured":"Autin P, Deshayes S, Lea J, Boisgerault N, Dupr\u00e9 E, Labarri\u00e8re N, et al. The DCMU herbicide shapes T-cell functions by modulating micro-RNA expression profiles. Front Immunol. 2022;13:925241.","journal-title":"Front Immunol"},{"key":"5963_CR95","doi-asserted-by":"publisher","first-page":"607044","DOI":"10.3389\/fimmu.2021.607044","volume":"12","author":"AN Renrick","year":"2021","unstructured":"Renrick AN, Thounaojam MC, de Aquino MTP, Chaudhuri E, Pandhare J, Dash C, et al. Bortezomib sustains T Cell function by inducing miR-155-mediated downregulation of SOCS1 and SHIP1. Front Immunol. 2021;12:607044.","journal-title":"Front Immunol"},{"issue":"9","key":"5963_CR96","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","volume":"204","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li F, Tian Y, Cao L, Gao Q, Zhang C, et al. Metformin enhances the antitumor activity of CD8(+) T lymphocytes via the AMPK-miR-107-Eomes-PD-1 pathway. J Immunol. 2020;204(9):2575\u201388.","journal-title":"J Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05963-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05963-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05963-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:04:59Z","timestamp":1734699899000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05963-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5963"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05963-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1131"}}